According to the Zhitong Finance App, Fuan Pharmaceutical (300194.SZ) released its 2026 semi-annual report. During the reporting period, the company achieved revenue of 839 million yuan, a year-on-year decrease of 8.82%. Net profit attributable to shareholders of listed companies was 95.7748 million yuan, a year-on-year decrease of 15.33%. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 86.4366 million yuan, a year-on-year decrease of 16.93%.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.